Knowledge Partners

 Economic Laws Practice       Avalon Consulting

 Technloogy Holdings   

July 15, 2011

New Wave of Life Sciences Firms

Economic Times has profiles of 3 new VC-backed Life sciences companies:

Cellworks Research

INVESTOR: Artiman Ventures

ACTIVITY: Drug discovery using a proprietary computer simulation platform to find new uses for old drugs in inflammation and cancer

POTENTIAL REVENUE STREAMS: Licensing drugs for development and marketing,selling its proprietary green chemistry technology to various industries

Vyome Biosciences

ACTIVITY: Researching drugs for wound healing,skin pigmentation,finding new uses for old drugs in dandruff and acne treatments

INVESTOR: Navam Capital

POTENTIAL REVENUE STREAMS: Licensing drugs for development and marketing to larger companies

Mitra Biotech.


INVESTOR: Kitven,Accel Partners,India Innovation Fund

ACTIVITY: Diagnostics to personalise cancer medicine in partnership with hospitals and drug companies

POTENTIAL REVENUE STREAMS: Offering testing services to cancer hospitals to match drugs to patients,partnering drug companies during clinical trials

Arun Natarajan is the Founder & CEO of Venture Intelligence, the leading provider of data and analysis on private equity, venture capital and M&A deals in India. View free samples of Venture Intelligence newsletters and reports. Email the author at